MedPath

ow dose chemoprophylaxis (LDCP) and reduction of pyelonephritic episodes and significant bacteriuria in children with meningomyelocele and clean intermittent catheterisation (CIC)

Not Applicable
Completed
Conditions
Meningomyelocele (MMC)
Not Applicable
Spina bifida
Registration Number
ISRCTN56278131
Lead Sponsor
niversity Medical Centre Utrecht (UMCU) (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
170
Inclusion Criteria

1. Neuropathic bladder-sphincter dysfunction
2. CIC and use of LDCP for at least 6 months
3. Good possibilities for communication
4. Written informed consent

Exclusion Criteria

1. Urinary tract infection (UTI) or - pyelonephritis at inclusion
2. Fever of unknown origin (e causa ignota [ECI])
3. Other neurologic diseases
4. Other diseases like IDDM that can cause UTI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Number of urinary tract infections<br>2. Number of pyelonephritic episodes
Secondary Outcome Measures
NameTimeMethod
Changes in antibiotic resistance patterns in the cultured uropathogens
© Copyright 2025. All Rights Reserved by MedPath